SINGH, Asheesh; SINGH, Parul. TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS. Journal of Drug Delivery and Therapeutics, India, v. 6, n. 5, p. 97–102, 2016. DOI: 10.22270/jddt.v6i5.1303. Disponível em: https://jddtonline.info/index.php/jddt/article/view/1303. Acesso em: 30 apr. 2026.